advertisement
Nasyrov E 36
Showing records 1 to 25 | Display all abstracts from Nasyrov E120637 Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years
Gassel CJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 3661-3670
120310 Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis
Nasyrov E
Ocular Immunology and Inflammation 2024; 0: 1-11
120824 Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma
Nasyrov E
BMC Ophthalmology 2024; 24: 264
120574 Two-Year Results of XEN Gel Stent Implantation for Pseudoexfoliative Glaucoma in Phakic versus Pseudophakic Eyes
Nasyrov E
Journal of clinical medicine 2024; 13:
121252 XEN45 gel stent in the treatment of pigmentary glaucoma: A two-year follow-up
Gassel CJ
European Journal of Ophthalmology 2025; 35: 172-180
120310 Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis
Merle DA
Ocular Immunology and Inflammation 2024; 0: 1-11
120637 Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years
Wenzel DA
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 3661-3670
120824 Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma
Gassel CJ
BMC Ophthalmology 2024; 24: 264
120574 Two-Year Results of XEN Gel Stent Implantation for Pseudoexfoliative Glaucoma in Phakic versus Pseudophakic Eyes
Merle DA
Journal of clinical medicine 2024; 13:
120310 Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis
Merle DA
Ocular Immunology and Inflammation 2024; 0: 1-11
120637 Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years
Wenzel DA
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 3661-3670
120574 Two-Year Results of XEN Gel Stent Implantation for Pseudoexfoliative Glaucoma in Phakic versus Pseudophakic Eyes
Merle DA
Journal of clinical medicine 2024; 13:
121252 XEN45 gel stent in the treatment of pigmentary glaucoma: A two-year follow-up
Nasyrov E
European Journal of Ophthalmology 2025; 35: 172-180
120310 Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis
Merle DA
Ocular Immunology and Inflammation 2024; 0: 1-11
120637 Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years
Wenzel DA
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 3661-3670
120574 Two-Year Results of XEN Gel Stent Implantation for Pseudoexfoliative Glaucoma in Phakic versus Pseudophakic Eyes
Merle DA
Journal of clinical medicine 2024; 13:
121252 XEN45 gel stent in the treatment of pigmentary glaucoma: A two-year follow-up
Wenzel DA
European Journal of Ophthalmology 2025; 35: 172-180
120637 Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years
Nasyrov E
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 3661-3670
120574 Two-Year Results of XEN Gel Stent Implantation for Pseudoexfoliative Glaucoma in Phakic versus Pseudophakic Eyes
Gassel CJ
Journal of clinical medicine 2024; 13:
120824 Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma
Merle DA
BMC Ophthalmology 2024; 24: 264
120310 Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis
Doycheva D
Ocular Immunology and Inflammation 2024; 0: 1-11
121252 XEN45 gel stent in the treatment of pigmentary glaucoma: A two-year follow-up
Wenzel DA
European Journal of Ophthalmology 2025; 35: 172-180
120824 Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma
Merle DA
BMC Ophthalmology 2024; 24: 264
121252 XEN45 gel stent in the treatment of pigmentary glaucoma: A two-year follow-up
Wenzel DA
European Journal of Ophthalmology 2025; 35: 172-180
120824 Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma
Merle DA
BMC Ophthalmology 2024; 24: 264
